Skip to main content

Thomas Maikowski Comment On Regulatory Notice 22-08

Comments: The problem is not the product, it is the breadth of knowledge of the solicitor. FINRA enforcement of the solicitor is more important and a better use of time and resources than restricting use of the product. There is no more complex product than indexed annuities and its numerous moving parts, possibly the most oversold by the most uninformed of all products available to the consumer yet I see little to no product restrictions.

Valdon Bill Comment On Regulatory Notice 22-08

I strongly disagree with making it harder to trade complex products, specifically leveraged and inverse funds. If I had to meet similar qualifications and go through much the same processes required for margin and options, then I would be tempted to simply go ahead and sign up for those as well or instead, which would expose me to dramatically higher risks than any ETF. It's quite likely many others would do the same. Meanwhile there will still be stocks where equally devastating losses could and sometimes do occur, so it isn't actually going to protect anyone.

Jerrold Crawford Comment On Regulatory Notice 22-08

Comments: Please do not restrict my access or use of leveraged ETFs. During the 2 years of the pandemic when no one in the family had work, trading leveraged ETFs constituted the main source of income to sustain the family. They may be 'complex products' but the ETF company manages the products, not the investor. As long as the risks are understood and investments are closely monitored the complexity of the instruments are someone else's responsibility. During my 15 years of usage of leveraged ETF instruments there has never been the slightest whiff of misfeasance or malfeasance.